RAY B Stock Overview
A medical technology company, provides software solutions for cancer treatment worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
RaySearch Laboratories AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 309.50 |
| 52 Week High | SEK 328.00 |
| 52 Week Low | SEK 123.60 |
| Beta | 1.09 |
| 1 Month Change | 32.83% |
| 3 Month Change | 16.35% |
| 1 Year Change | 111.99% |
| 3 Year Change | 387.40% |
| 5 Year Change | 298.33% |
| Change since IPO | 54,518.29% |
Recent News & Updates
RayStation And RayCare Upgrades Will Streamline Adaptive Treatment Planning
Integration of AI and new treatment modules is anticipated to boost efficiency, driving demand and potential revenue growth for RaySearch.RaySearch Laboratories AB (publ)'s (STO:RAY B) 43% Price Boost Is Out Of Tune With Earnings
May 13
RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year
May 09Recent updates
RayStation And RayCare Upgrades Will Streamline Adaptive Treatment Planning
Integration of AI and new treatment modules is anticipated to boost efficiency, driving demand and potential revenue growth for RaySearch.RaySearch Laboratories AB (publ)'s (STO:RAY B) 43% Price Boost Is Out Of Tune With Earnings
May 13RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year
May 09RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00
Apr 25RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00
Apr 09RaySearch Laboratories' (STO:RAY B) Earnings May Just Be The Starting Point
Mar 01RaySearch Laboratories' (STO:RAY B) Dividend Will Be Increased To SEK3.00
Feb 26RaySearch Laboratories AB (publ)'s (STO:RAY B) Shares Climb 28% But Its Business Is Yet to Catch Up
Nov 09RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
May 21The Returns At RaySearch Laboratories (STO:RAY B) Aren't Growing
May 11RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends
Oct 04Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?
Jul 10Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?
Nov 17Shareholder Returns
| RAY B | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | -1.6% | 1.7% | 0.4% |
| 1Y | 112.0% | 40.9% | -3.7% |
Return vs Industry: RAY B exceeded the Swedish Healthcare Services industry which returned 39.3% over the past year.
Return vs Market: RAY B exceeded the Swedish Market which returned -3% over the past year.
Price Volatility
| RAY B volatility | |
|---|---|
| RAY B Average Weekly Movement | 11.8% |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in SE Market | 13.7% |
| 10% least volatile stocks in SE Market | 4.2% |
Stable Share Price: RAY B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: RAY B's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 422 | Johan Lof | www.raysearchlabs.com |
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions.
RaySearch Laboratories AB (publ) Fundamentals Summary
| RAY B fundamental statistics | |
|---|---|
| Market cap | SEK 10.61b |
| Earnings (TTM) | SEK 223.62m |
| Revenue (TTM) | SEK 1.27b |
Is RAY B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RAY B income statement (TTM) | |
|---|---|
| Revenue | SEK 1.27b |
| Cost of Revenue | SEK 102.86m |
| Gross Profit | SEK 1.16b |
| Other Expenses | SEK 940.05m |
| Earnings | SEK 223.62m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 08, 2025
| Earnings per share (EPS) | 6.52 |
| Gross Margin | 91.88% |
| Net Profit Margin | 17.66% |
| Debt/Equity Ratio | 0% |
How did RAY B perform over the long term?
See historical performance and comparisonDividends
Does RAY B pay a reliable dividends?
See RAY B dividend history and benchmarks| RaySearch Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | May 23 2025 |
| Dividend Pay Date | May 30 2025 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 8 days |
Does RAY B pay a reliable dividends?
See RAY B dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 01:06 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
RaySearch Laboratories AB (publ) is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Hans Mähler | DNB Markets |
| Hans Mähler | Handelsbanken Capital Markets |